Get a glimpse into our company and investor data—powered by the PitchBook Platform
Biomark Diagnostics Inc is a Canada based oncology-focused company. It is engaged in the development of advanced stage cancer diagnostic business. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection.
You’re viewing a free company profile from the PitchBook Platform. To explore Biomark Diagnostics’s full profile, request a free trial.
52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
---|---|---|---|---|---|
$0.03 - $0.08 | $2.38M | $0.04 | 7.74K | 62.8M |
In Thousands,
USD |
TTM
30-Sep-2018
|
FY 2018
31-Mar-2018
|
FY 2017
31-Mar-2017
|
FY 2016
31-Mar-2016
|
---|---|---|---|---|
Enterprise Value | 2,789 | 3,313 | 3,865 | 5,956 |
Revenue | 0 | 0 | 0 | |
EBITDA | (464) | (566) | (545) | (1,068) |
Net Income | (464) | (566) | (545) | (1,068) |
Total Assets | 36 | 40 | 30 | 26 |
Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
---|
This information is reserved for PitchBook Platform users. To explore Biomark Diagnostics‘s full profile, request access.
Request full access to PitchBook